J&J Nizoral AD dandruff shampoo marketing may emphasize Rx heritage.
This article was originally published in The Rose Sheet
Executive Summary
J&J OTC NIZORAL AD DANDRUFF SHAMPOO GRANTED FDA APPROVAL for the control of flaking, scaling and itching. The agency cleared Johnson & Johnson's application to switch its ketoconazole shampoo (NDA 20-310) from prescription to over-the-counter status on Oct. 10. The product, which contains 1% of the active ingredient, will be marketed by J&J's Consumer Products Group. J&J will continue to sell prescription Nizoral 2% ketoconazole shampoo with a new indication: treatment of tinea versicolor, a topical fungal infection.